Evidence map›Paper›PMID 32980614›Full record

SynthesisSleep medicine reviews2021

A systematic review of COVID-19 and obstructive sleep apnoea.

Michelle A Miller, Francesco P Cappuccio

Registry-linked trialOpen access · greenAbstract readSystematic Review
In one paragraph

Synthesis in Sleep medicine reviews, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05290350 (Obstructive Sleep Apnea in Patients With Long COVID-19 Fatigue), which is not on this map. Cited by 81 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
81citing papers in PubMed, 2 pooled it
14.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05290350 unknown statusnot on this mapstarted 2022, after this paper: background citation

Obstructive Sleep Apnea in Patients With Long COVID-19 Fatigue: a Multicentre Prospective Cohort Study

TypeobservationalSponsorCentro Hospitalar Universitario do AlgarveRan2022 to 2023Enrolled300ConditionsLong COVID, Fatigue, Obstructive Sleep Apnea of AdultArmsOSA
3 · Its place in the literature

Who cites it

81 citing papers in PubMed, 2 syntheses or guidelines pooled it, 165 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Severity classification of obstructive sleep apnea using AASM and SEPAR criteria: A cross-sectional reclassification analysis.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

21 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Michelle A MillerDivision of Health Sciences (Mental Health & Wellbeing), Warwick Medical School, University of Warwick, Coventry, UK. Electronic address: Michelle.miller@warwick.ac.uk.
Francesco P CappuccioDivision of Health Sciences (Mental Health & Wellbeing), Warwick Medical School, University of Warwick, Coventry, UK; University Hospitals Coventry & Warwickshire NHS Trust, Coventry, UK.
University Hospitals Coventry and Warwickshire NHS Trust · GBUniversity of Warwick · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aims of the study were to review the rapidly emerging COVID-19 literature to determine 1) the relationship between obstructive sleep apnoea (OSA) and adverse COVID-19 outcomes and, 2) potential causal mechanisms 3) what effect COVID-19 has had on OSA diagnosis and 4) what effect COVID-19 has had on treatment and management of OSA during this period. PubMed was systematically searched up to 020620. Studies were included if they had examined the relationship between COVID-19 and OSA. Studies were included that were in English and had the full text available. The findings from this study suggest that many of the risk factors and co-morbidities associated for OSA which include obesity, hypertension and diabetes mellitus are associated with poor COVID-19 outcomes. There are plausible mechanisms by which OSA may independently increase one's risk of morbidity and mortality associated with COVID-19 and data from the newly published CORONADO study suggests that OSA treated patients may be at increased risk of death from COVID-19. It is clear that the pandemic has had a major effect on the treatment management and diagnosis of OSA and moving forward it may be necessary to explore new diagnosis and treatment pathways for these individuals.

Indexed as

ComorbidityCOVID-19Continuous Positive Airway PressureDiabetes MellitusHumansHypertensionMelatoninObesityRisk FactorsSARS-CoV-2Sleep Apnea, ObstructiveMelatoninCPAPInflammationMelatoninOSASleepVitamin D

Identifiers

PMID32980614
PMCPMC7833740
OpenAlexW3084108702

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.